United States · 
Who invested in Nome Bio?
Nome Bio's investors include Refactor Capital and Twelve Below.
United States · Seed startup
Who invested in Nome Bio
Funding summaryUpdated 26 Oct 2026
$2.7Mraised across 1 round since 2025, from 1 source
- Latest round
- Seed, $2.7MOct 2025
- Investors
- 2
The rounds
- Oct 2025
Founders and team
From Nome Bio's own website: 1 founder, 5 on the team.
Stevie RingelFounder & CEO
- Tehmina MasudChief Scientific Officer
- Meghan DegeleHead of Clinical Operations and Partnerships
- Dan ClarkNome Legal Counsel
- Flawnson TongStaff Engineer
- Sukh SekhonStaff Engineer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nome Bio
How much has Nome Bio raised?
Nome Bio has raised $2.7M across 1 round since 2025.
When did Nome Bio last raise?
Nome Bio's most recent round was a Seed of $2.7M in Oct 2025.
What was Nome Bio's biggest round?
Its most recent round, $2.7M in Oct 2025, is also its largest on record.
Who backed Nome Bio first?
Nome Bio's first round on record, in Oct 2025, was backed by Refactor Capital and Twelve Below.
What stage is Nome Bio at?
Nome Bio's latest named round is a Seed, in Oct 2025.
Where is Nome Bio based?
Nome Bio is based in the United States.
Companies like Nome Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.